Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
An account is an optional way to support the work we do. Find out more.
The Morning Lead
'My son is not there anymore': How young people with psychosis are falling through the cracks
The earlier a person’s symptoms are treated, the better the outcome – but many people with psychosis or schizophrenia struggle to get access to care.
12.05am, 29 Feb 2024
28.2k
WHEN YOU ASK Kielan Kenny how old he is, he replies 15. He has lost three years of his life.
He was social. He had a dry sense of humour. Now he needs 24-hour care.
Kielan turned 18 last September. He is, by definition, now an adult. But, in his mind, he is still a child. Time has stood still for Kielan since 2021 when he had an intense psychotic episode at the age of 15.
In the years leading up to this, like many children, Kielan had periods of anxiety. However, unlike many, he also has a rare genetic condition – his brain and body were developing in a different way.
Kielan has 22q, he is also autistic and has cognitive issues. He experiences regular psychotic episodes – which can last weeks at a time – and displays symptoms of schizophrenia.
Sometimes referred to as 22q11.2 deletion syndrome or DiGeorge syndrome, 22q is the most common rare chromosomal condition after Down syndrome.
People with 22q have a 25% chance of developing schizophrenia, much higher than the 1% chance among the general population. The only other situation where a person is so predisposed to develop schizophrenia is if both their parents have experienced psychosis.
Karin Kenny and her son Kielan The Kenny family
The Kenny family
Noteworthy, the crowdfunded community-led investigative platform from The Journal, supports independent and impactful public interest journalism.
Kielan had to drop out of school and his mother cares for him full time. Karin Kenny believes her son would be in a very different position now if he had received early intervention when he first displayed signs of psychosis at age 12.
Because he needs help across a variety of medical disciplines, he has largely fallen through the cracks.
Karin said she has been referred from doctor to doctor, at various times being told Kielan needs to be treated via the Child and Adult Mental Health Services (CAMHS), the Children’s Disability Network Team (CDNT) or psychosis services.
Autistic children are often excluded from CAMHS and instead referred back to their local disability team – despite the fact they may have ill mental health. If conditions like anxiety and depression are untreated before puberty, the severity often deteriorates and in some cases develop into psychosis.
Delayed treatment for psychosis can impact people’s quality of life for decades. As previously reported by The Journal, nobody under 18 has access to an early intervention psychosis (EIP) team in Ireland.
However, the country’s first CAMHS EIP team is expected to start seeing patients in the near future. This will serve the Dublin and North Wicklow area and “will allow young people to transition in a seamless manner if required”, a HSE spokesperson said.
Since he turned 18, Kielan is essentially back to square one – there is confusion over whether or not he needs to be treated by Adult Mental Health Services, EIP services, or a disability team.
When asked about the Kenny family’s struggle to access services, a spokesperson for the HSE said that they “regret that any child and their family would have difficulty in accessing our services”. They added:
In all such circumstances the HSE endeavours to work with all relevant people, including the children’s family, to ensure that they receive appropriate care and timely intervention.
High risk of developing schizophrenia
Up to one in 2,000 people are thought to have 22q, but it remains largely unknown and often misunderstood – even in the medical community. It’s estimated about 2,500 people in Ireland have 22q, but many are undiagnosed.
The condition occurs when a small part of chromosome 22 is missing. There are around 180 ways 22q can affect a person including psychosis, which occurs when people lose contact with reality.
The main symptoms associated with a psychotic episode are hallucinations and disturbed thoughts. Some people have a one-off psychotic episode, but don’t develop a related disorder. However, others develop schizophrenia, delusional disorder or schizoaffective disorder.
The earlier a person’s symptoms are treated, the better the outcome. If there is a delay in treating psychosis, it can develop into schizophrenia and severe cognitive decline. Schizophrenia is treatable but not curable.
Kielan (left) and his older brother Aaron pictured in 2016 Karin Kenny
Karin Kenny
Kielan first started displaying signs of paranoia when he was 12.
“He removed all the posters off the wall in his bedroom and removed all the toys. He thought they were looking at him. He would keep the curtains closed all the time,” Karin explained.
“He started shoving things down the toilet and start screaming at the toilet.”
During one of his first psychotic episodes, Kielan kept referring to Alex. When asked who this was, he pointed into his mouth. Alex was inside him.
Kielan has been on various antipsychotic medications since then, but Karin believes doctors have not yet landed on a combination that works for him.
“He has lost three years of his life. When you ask Kielan how old he is, he replies 15. It’s like he has not moved on in life,” she said.
Simon, Kielan and Aaron Kenny pictured in December 2023 Karin Kenny
Karin Kenny
His psychotic episodes regularly last for weeks at a time, sometimes with one week of a break in between.
During an episode, Kielan typically wants to shower up to 15 times a day or be constantly driven in the car. He often does not eat for days at a time.
Kielan can get incredibly agitated, at times becoming violent. Sometimes he will repeatedly hit his head on a wall.
“I do get scared, he’s big, he’s strong,” Karin said.
Falling through the cracks
Karin firmly believes if Kielan had received early intervention for psychosis, he would be a very different person now and could have finished school.
“If he got help with his anxiety, that could have prevented the cognitive decline and the psychosis. We probably would still have the child that we had before 15, but he’s not there anymore.”
Dr Suzanne Kelleher and Wesley Mulcahy run the 22q clinic at CHI Crumlin Órla Ryan
Órla Ryan
People like Kielan often struggle to access support because they don’t “neatly fit” into “narrow” service provision parameters, Wesley Mulcahy, 22q complex care coordinator at CHI Crumlin, explained.
Mulcahy said – due to a lack of understanding of 22q among some medical professionals and a lack of communication between services – the “complex” nature of children’s needs isn’t always “appreciated” by the teams who treat them.
Some medical staff “fight to the bone” to not take on certain children, he said.
“I’ve heard things like, ‘That child is now 16 and a half, he’s only with us until he’s 18, will we just wait?’ It’s very frustrating because I can only take things to a certain point and, even if I’ve done all I can do, that doesn’t guarantee a positive outcome.”
Early intervention can make a difference
If a child’s anxiety or depression is treated sooner, they are much less likely to experience psychosis – whether or not they have 22q.
“By managing those symptoms, we might not find ourselves having the numbers of psychotic young people that we have,” Mulcahy explained.
Paediatric consultant Dr Suzanne Kelleher said CAMHS will sometimes not treat a child because their symptoms are not severe enough.
“CAMHS will say, ‘They’re not bad enough for us, we’re only seeing children who are self harming, with suicidal ideation’. And yet, we know that untreated anxiety in this population exponentially increases the risks of development of psychosis,” she said of children with 22q.
The Journal and Noteworthy are currently exploring how a lack of access to services is impacting people with psychosis and schizophrenia; read more articles in the Falling Through the Cracks series here.
Advertisement
When we put these issues to the HSE, the spokesperson said that teams across Primary Care, Disabilities and CAMHS have a joint working protocol which “aims to make the referral process between these services more seamless”.
In cases where it appears that more than one service could best meet a child’s needs, “consultation should take place with the other service(s) to determine which is the most appropriate or whether a joint approach is needed”.
When deciding if a child or adolescent needs to attend CAMHS, “a number of factors are considered” including the person’s clinical presentation, their level of social and family support, and the availability of resources and treatment options at primary care level or within community networks.
If a young person presents with complex needs and a moderate to severe mental disorder at the same time, it is the role of CAMHS to “provide appropriate multidisciplinary mental health assessment and treatment for the mental disorder”.
This may involve shared care with other agencies.
Lack of investment in services ‘foolish’
Kelleher said 22q could be diagnosed sooner if it was added to the list of conditions covered by the heel prick test – screening carried out on newborns to diagnose rare but serious conditions. Prenatal screening could also detect 22q, but it is not typically included in the conditions tested for in Ireland.
A spokesperson said expanding the heel prick test is a priority for the Minister for Health, and the National Screening Advisory Committee (NSAC) has been actively progressing work in this regard.
NSAC, an independent expert group, invites stakeholders – including members of the public, the HSE and other medical professionals – to make proposals for the introduction of new population-based screening programmes or changes to existing programmes.
In its 2021 call for submissions, NSAC received a proposal for a screening programme for 22q. It was one of 34 rare but serious conditions put forward for consideration.
All proposals will be examined by NSAC before a decision is made on whether or not to put it forward to the next stage – an evidence review which examines aspects such as clinical effectiveness and safety.
Changing the trajectory of a person’s life
“Early screening means you can do something that could change the trajectory of the person’s life, saving a lot of money and suffering,” Professor Stéphan Eliez said.
Professor Stéphan Eliez says early screening and intervention could change the trajectory of a person’s life Órla Ryan
Órla Ryan
Eliez, who works at Geneva University’s Laboratory in Child and Adolescent Psychiatry, said if anxiety disorders were treated sooner it would prevent some people from developing psychosis.
“If you treat them you can avoid cognitive decline during puberty and significantly reduce the emergence of psychosis.”
Not investing in early intervention for psychosis is the definition of “penny-wise, pound-foolish”, according to Professor Jacob Vorstman, who specialises in child and adolescent psychiatry.
“The most important reason [to intervene] is because you mitigate the trajectory of the child developing psychosis. But also, in the long run, a child going without appropriate care is going to cost a lot more because the prognosis is much worse.”
Professor Jacob Vorstman says not investing in early intervention for psychosis is "penny-wise, pound-foolish" Órla Ryan
Órla Ryan
Vorstman, who is conducting research on 22q at The Hospital for Sick Children (SickKids) in Toronto, said the earlier the intervention, the more likely a child is to stay in school, socialise and lead a fuller life.
“The longer you are in a state of psychosis without it being properly treated, the worse it is for your brain.”
‘No established’ pathway of care for adults
Kelleher started a 22q clinic at the children’s hospital in Crumlin in 2017. Referrals kept increasing and in 2021 – working alongside the advocacy group 22q11 Ireland – she secured funding from the HSE for the complex care coordinator role. Mulcahy took up the position in November 2021.
The clinic takes place every second Tuesday. The plan is to have weekly sessions but, due to a HSE embargo on recruitment, this hasn’t happened yet. While Mulcahy’s role is funded until 2026, more administrative support is needed.
Around 120 children were seen at the clinic in 2023. Kelleher typically meets five children per clinic and spends at least 45 minutes with each child and their parents. They discuss the child’s needs, and she links them to other specialists.
While under 18s currently don’t have access to EIP teams, adults with 22q – and indeed people with other rare genetic conditions – don’t have access to a care coordinator. The 22q clinic tries to ensure a smooth transfer of care from child to adult services, but this is not always possible.
We put this to the Department but did not receive a direct response to this query. The spokesperson did refer to the ongoing development of the Rare Disease Plan and resulting actions that will be required for services.
Ideally, this model of care coordination could be replicated at other hospitals to cater for adults with 22q and patients of all ages with other rare diseases, Anne Lawlor said.
Anne Lawlor and her daughter, Áine Lawlor Noleen Kavanagh
Noleen Kavanagh
She set up 22q11 Ireland in 2007 due to a lack of support for people who have the condition. Anne’s daughter Áine (40) has 22q and, throughout her life, has struggled to get access to appropriate and timely care.
The HSE funded Mulchay’s role after Lawlor and Kelleher submitted a business plan, outlining why a care coordinator was needed. While welcoming the fact his position has been funded until at least 2026, Lawlor said more needs to be done.
“We had to really fight to get Wesley,” she said, adding that administrative staff and a psychologist should also be hired to work at the clinic.
The care is well coordinated within the walls of Crumlin hospital, but outside that we’re back to abysmal, to long waiting lists. And what happens when the kids turn 18?
Ultimately, Lawlor believes Ireland needs a rare disease centre where patients can be treated and the conditions themselves can be researched.
In December 2023, Health Minister Stephen Donnelly announced a new patient forum to “ensure that patients and families’ voices are central” to the Government’s new Rare Disease Strategy. Earlier this month, the HSE approved funding of €20 million for seven “life-enhancing” drugs for rare but debilitating conditions.
A 'healthcare passport' for children with 22q is being launched at CHI Crumlin today CHI at Crumlin
CHI at Crumlin
Lawlor, who is also on the board of Rare Diseases Ireland, said news like this is welcome but promotes the misconception that treating rare conditions is “all about very expensive drugs”.
“I don’t want millions of euro, I want an ENT (ear, nose, and throat) appointment for my daughter.”
Until rare diseases are researched in more detail and their treatments better funded, Lawlor said families like hers will continue to “live in fear”.
“They’re dependent on people who have the power, at the stroke of a pen, to either grant services or take away what they already have.”
Today is Rare Disease Day. For more information and support related to rare diseases, click here. More information and support related to 22q can be accessed here.
—
FALLING THROUGH THE CRACKS
How are inadequate services impacting young people with psychosis?
This article is part of a wider series, Falling Through the Cracks, by The Journal and Noteworthy which is exploring access to services for people with psychosis and/or schizophrenia.
We would like to hear from teenagers and young adults – or their parents / guardians – who have been impacted by the lack of services available to them. Please emailorla@thejournal.ie to share your story.
Supported by the Rosalynn Carter Fellowship for Mental Health Journalism in the Republic of Ireland in partnership with Headline, a Shine programme.
—
If you have been affected by any of the issues mentioned in this article, you can reach out for support through the following helplines. These organisations also put people in touch with long-term supports:
Shine - 01 860 1610 or 086 040 7701, phone lines are monitored Monday to Friday 9am to 5pm (mental health difficulties including schizophrenia and psychosis, individual and family support)
Samaritans- 116 123 or email jo@samaritans.org (suicide, crisis support)
Text About It- text HELLO to 50808 (mental health issues)
Aware – 1800 80 48 48 (depression, anxiety)
Pieta House – 1800 247 247 or text HELP to 51444 – (suicide, self-harm)
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
High pressure 'omega block' means warm and sunny spells are here to stay until next week
8 mins ago
388
1
trade war
Mary Lou McDonald tells Dáil that counter EU tariffs on the US are not in Ireland's interest
15 mins ago
788
1
RIP
'An uber-creative firecracker': Tributes as film star Val Kilmer dies aged 65
7 hrs ago
40.1k
28
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 161 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 143 partners can use this purpose
Use limited data to select advertising 113 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 39 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 35 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 134 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 61 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say